Catalysts for Graviti Pharmaceuticals Inc
28 tracked
Mar 4, 2026
approval
GLIPIZIDE — FDA approval
Graviti Pharmaceuticals Inc
→
Feb 17, 2026
approval
AMLODIPINE BESYLATE — FDA approval
Graviti Pharmaceuticals Inc
→
Jan 28, 2026
recall
Graviti Pharmaceuticals Private Limited recall (Cls II)
Graviti Pharmaceuticals Inc
→
Jan 26, 2026
approval
AMLODIPINE BESYLATE — FDA approval
Graviti Pharmaceuticals Inc
→
Dec 29, 2025
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Graviti Pharmaceuticals Inc
→
Dec 23, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
Graviti Pharmaceuticals Inc
→
Oct 29, 2025
recall
Graviti Pharmaceuticals Private Limited recall (Cls II)
Graviti Pharmaceuticals Inc
→
Sep 19, 2025
approval
LOSARTAN POTASSIUM — FDA approval
Graviti Pharmaceuticals Inc
→
Oct 31, 2024
approval
TRAMADOL HYDROCHLORIDE — FDA approval
Graviti Pharmaceuticals Inc
→
Oct 31, 2024
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Graviti Pharmaceuticals Inc
→
Aug 2, 2024
approval
TRAMADOL HYDROCHLORIDE — FDA approval
Graviti Pharmaceuticals Inc
→
May 28, 2024
approval
TRAMADOL HYDROCHLORIDE — FDA approval
Graviti Pharmaceuticals Inc
→
Feb 1, 2024
approval
TRAMADOL HYDROCHLORIDE — FDA approval
Graviti Pharmaceuticals Inc
→
Dec 19, 2023
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Graviti Pharmaceuticals Inc
→
Dec 18, 2023
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Graviti Pharmaceuticals Inc
→
Jun 7, 2023
approval
AMLODIPINE BESYLATE — FDA approval
Graviti Pharmaceuticals Inc
→
Sep 18, 2018
approval
TRAMADOL HYDROCHLORIDE — FDA approval
Graviti Pharmaceuticals Inc
→
Sep 18, 2018
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Graviti Pharmaceuticals Inc
→
Apr 3, 2018
approval
AMLODIPINE BESYLATE — FDA approval
Graviti Pharmaceuticals Inc
→
Jun 16, 2017
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Graviti Pharmaceuticals Inc
→
Dec 3, 2015
approval
AMLODIPINE BESYLATE — FDA approval
Graviti Pharmaceuticals Inc
→
May 11, 2015
approval
TRAMADOL HYDROCHLORIDE — FDA approval
Graviti Pharmaceuticals Inc
→
May 11, 2015
approval
TRAMADOL HYDROCHLORIDE — FDA approval
Graviti Pharmaceuticals Inc
→
Sep 19, 2014
approval
AMLODIPINE BESYLATE — FDA approval
Graviti Pharmaceuticals Inc
→
Apr 13, 2012
approval
AMLODIPINE BESYLATE — FDA approval
Graviti Pharmaceuticals Inc
→
Jul 26, 2006
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
Graviti Pharmaceuticals Inc
→
Oct 30, 2002
approval
TRAMADOL HYDROCHLORIDE — FDA approval
Graviti Pharmaceuticals Inc
→
Jun 25, 2002
approval
TRAMADOL HYDROCHLORIDE — FDA approval
Graviti Pharmaceuticals Inc
→